VTGN

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

VistaGen Therapeutics Inc

NASDAQ | VTGN

3.91

USD

$0.00

(

0.00%

)

At Close (As of Oct 13, 2025)

$123.64M

Market Cap

-

P/E Ratio

-1.79

EPS

$4.38

52 Week High

$1.90

52 Week Low

HEALTHCARE

Sector

VTGN Chart

Recent Chart
Price Action

VTGN Technicals

Tags:

VTGN Earnings

Yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit $486K
Total Revenue $486K
Cost Of Revenue $635K
Costof Goods And Services Sold $635K
Operating Income -$56M
Selling General And Administrative $17M
Research And Development $39M
Operating Expenses $56M
Investment Income Net -
Net Interest Income $4.6M
Interest Income $4.6M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $635K
Income Before Tax -$51M
Income Tax Expense $7K
Interest And Debt Expense -
Net Income From Continuing Operations -$51M
Comprehensive Income Net Of Tax -
Ebit -$56M
Ebitda -$55M
Net Income -$51M

Revenue & Profitability

Earnings Performance

VTGN Financials

yearly Balance Sheet (As of Mar 31, 2025)

Field Value (USD)
Total Assets $84M
Total Current Assets $82M
Cash And Cash Equivalents At Carrying Value $67M
Cash And Short Term Investments $67M
Inventory -
Current Net Receivables -
Total Non Current Assets $2.3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $13M
Other Current Assets $1.6M
Other Non Current Assets -
Total Liabilities $14M
Total Current Liabilities $13M
Current Accounts Payable $653K
Deferred Revenue -
Current Debt -
Short Term Debt $561K
Total Non Current Liabilities $1.3M
Capital Lease Obligations $1.5M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.5M
Other Current Liabilities $8.8M
Other Non Current Liabilities -
Total Shareholder Equity $70M
Treasury Stock -
Retained Earnings -$408M
Common Stock $29K
Common Stock Shares Outstanding $31M

yearly Cash Flow (As of Mar 31, 2025)

Field Value (USD)
Operating Cashflow -$42M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $635K
Capital Expenditures $191K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$13M
Cashflow From Financing $3.2M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$51M

yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit $486K
Total Revenue $486K
Cost Of Revenue $635K
Costof Goods And Services Sold $635K
Operating Income -$56M
Selling General And Administrative $17M
Research And Development $39M
Operating Expenses $56M
Investment Income Net -
Net Interest Income $4.6M
Interest Income $4.6M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $635K
Income Before Tax -$51M
Income Tax Expense $7K
Interest And Debt Expense -
Net Income From Continuing Operations -$51M
Comprehensive Income Net Of Tax -
Ebit -$56M
Ebitda -$55M
Net Income -$51M

VTGN News

VTGN Profile

VistaGen Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

VistaGen Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for anxiety, depression, and other central nervous system disorders. Headquartered in South San Francisco, California, VistaGen is advancing its proprietary drug candidates, including AV-101, which aim to address significant unmet medical needs in the mental health space. The company's commitment to addressing CNS disorders positions it as a promising player in the evolving landscape of mental health therapeutics, with a robust pipeline that leverages its expertise in neuropharmacology.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
INTC
-3.78%
$36.36
PLUG
+13.30%
$3.87
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
EPWK
-21.60%
$0.09
QBTS
+22.83%
$40.56
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
GPUS
-9.45%
$0.47
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
DVLT
-12.36%
$1.66
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
RGTZ
-50.00%
$9.30
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VZ
-0.27%
$39.74
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
INTC
-3.78%
$36.36
PLUG
+13.30%
$3.87
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
EPWK
-21.60%
$0.09
QBTS
+22.83%
$40.56
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
GPUS
-9.45%
$0.47
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
DVLT
-12.36%
$1.66
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
RGTZ
-50.00%
$9.30
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VZ
-0.27%
$39.74
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.